510(k) device
Venofer Pump
Renal Solutions, Inc. · Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI, Class II) · First FDA decision Jul 9, 2010, newest Aug 17, 2012Kidney failure and dialysis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
1
Naming "Venofer"
MAUDE reports
0
Brand "Venofer", since 2015
PubMed studies
92
Mentioning "Venofer"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Venofer Pump
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- VENOFER PUMP510(k)
K121497 · Decided Aug 17, 2012 · 88 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Venofer: Intravenous Iron TherapyNational analysisReview closedCAG-00080NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Venofer", any status and sponsor, newest update first.
Vifor Fresenius Medical Care Renal PharmaNot on our public-company list
NCT03214627 · 88 participants · Start Dec 10, 2018 · Primary completion May 21, 2019
Device: Anemia Control Model (ACM) · For: Anemia; End Stage Renal Disease
Sites: London, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Venofer", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KDI
25,025 reports: 21,247 malfunction, 2,993 injury, 752 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Fresenius Medical Care Holdings, Inc. dba Renal Solutions
Z-2082-2013 · Started Apr 1, 2013 · Posted by FDA Aug 26, 2013
Reason given: Product is being recalled because the combination of the current 50 mg vial, the 2008 MeDS pump, and the 2008 MeDS pump tubing Set for CombiSet Bloodlines can lead to a situation where Venofer(R) delivery does not meet dosage accuracy requirements. This may lead to a slight over or under delivery of Venofer(R) that...
Cause as FDA categorized it: Device Design · Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI)
Published research
The most relevant PubMed records for "Venofer"[tiab]. The summary above synthesizes these.
- Influence of Carnicor, Venofer, and Sevelamer on the levels of genotoxic damage in end-stage renal disease patients.
Pastor S, Coll E, Rodríguez-Ribera L, et al. · Environ Mol Mutagen · 2018Research Support, Non-U.S. Gov't
- Intravenous Iron-Carbohydrate Nanoparticles and Their Similars. What Do We Choose?
Mehedinti AM, Capusa C, Andreiana I, et al. · Maedica (Bucur) · 2022Editorial
- Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy.
Mehta KJ · Stem Cell Rev Rep · 2022Review, Research Support, Non-U.S. Gov't
- Dental pulp mesenchymal stem/stromal cells labeled with iron sucrose release exosomes and cells applied intra-nasally migrate to intracerebral glioblastoma.
Altanerova U, Benejova K, Altanerova V, et al. · Neoplasma · 2016
- Iron oxide and iron oxyhydroxide nanoparticles impair SARS-CoV-2 infection of cultured cells.
DeDiego ML, Portilla Y, Daviu N, et al. · J Nanobiotechnology · 2022
- [Anaphylactic reaction after Fe-injection].
Fiechter R, Batschwaroff M, Conen D · Praxis (Bern 1994) · 2005Case Reports, English Abstract
- Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
Praschberger M, Cornelius C, Schitegg M, et al. · Pharm Dev Technol · 2015Comparative Study, Research Support, Non-U.S. Gov't
- Probing Subcellular Iron Availability with Genetically Encoded Nitric Oxide Biosensors.
Sevimli G, Alston AE, Funk F, et al. · Biosensors (Basel) · 2022
- Parenteral iron therapy exacerbates experimental sepsis.
Zager RA, Johnson AC, Hanson SY · Kidney Int · 2004Research Support, U.S. Gov't, P.H.S.
- Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia.
Altanerova U, Babincova M, Babinec P, et al. · Int J Nanomedicine · 2017Video-Audio Media
- Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S, Chiu DY, Peebles G, et al. · J Ren Care · 2009Comparative Study, Multicenter Study
Other devices of this type
Also filed under product code KDI.
- NxStage System One with Cartridge Express (CAR-170-E and CAR-172-E)Nxstage Medical, Inc. · 510(k) 2024
- Tablo Hemodialysis System (PN-0008000, PN-0006000U)Outset Medical, Inc. · 510(k) 2026
- Aquadex FlexFlow System 2.0Chf Solutions, Inc. · 510(k) 2020
- NxStage Cartridge Express with SpeedswapNxstage Medical, Inc. · 510(k) 2019
- multiFiltratePRO SystemFresenius Medical Care Renal Therapies Group, LLC · 510(k) 2026
- Elisio-HNipro Medical Corporation · 510(k) 2026
- FX CorAL 40Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
- FX CorAL 60 (F00012969)Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.